Healthcare provider profile · identity verified

Hamid-U-Rahman Khalili, ARNP

Nurse Practitioner · JACKSONVILLE, FL · NPI 1609194653

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	197	47
Atorvastatin Calcium	Atorvastatin Calcium	138	52
Amlodipine Besylate	Amlodipine Besylate	130	48
Lisinopril	Lisinopril	99	41
Losartan Potassium	Losartan Potassium	95	34
Hydrochlorothiazide	Hydrochlorothiazide	88	27
Carvedilol	Carvedilol	87	27
Ventolin Hfa	Albuterol Sulfate	86	18
Rosuvastatin Calcium	Rosuvastatin Calcium	83	28
Furosemide	Furosemide	78	21
Tizanidine Hcl	Tizanidine Hcl	77	26
Metformin Hcl	Metformin Hcl	74	24
Omeprazole	Omeprazole	70	18
Pantoprazole Sodium	Pantoprazole Sodium	70	18
Trazodone Hcl	Trazodone Hcl	69	17
Albuterol Sulfate Hfa	Albuterol Sulfate	67	15
Buspirone Hcl	Buspirone Hcl	63	12
Famotidine	Famotidine	62	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	19
Tamsulosin Hcl	Tamsulosin Hcl	52	17
Levothyroxine Sodium	Levothyroxine Sodium	50	17
Meloxicam	Meloxicam	48	12
Ozempic	Semaglutide	46	suppressed
Ibuprofen	Ibuprofen	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	18
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Celecoxib	Celecoxib	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Metoprolol Succinate	Metoprolol Succinate	32	12
Nifedipine Er	Nifedipine	31	suppressed
Eliquis	Apixaban	30	11
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	12
Fluticasone Propionate	Fluticasone Propionate	28	11
Montelukast Sodium	Montelukast Sodium	27	11
Spironolactone	Spironolactone	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	26	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Naproxen	Naproxen	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Baclofen	Baclofen	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Atrovent Hfa	Ipratropium Bromide	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Glipizide	Glipizide	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Humalog	Insulin Lispro	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Allopurinol	Allopurinol	12	suppressed
Atenolol	Atenolol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clonidine	Clonidine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Lactulose	Lactulose	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error